Bruker Quarterly Balance Sheet
NASDAQ: BRKRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bruker financial position
As of Jun 30, 2026, Bruker reported total assets of $6.05 billion, down 4.5% from a year earlier against total liabilities of $3.65 billion. Shareholders' equity stood at $2.40 billion, or 39.7% of assets. The company held $184.9 million in cash and equivalents against $1.82 billion of debt, a net debt position of $1.64 billion.
The current ratio (current assets divided by current liabilities) was 1.85, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.76.
Summary generated from market data by MetaCap's automated system. Methodology
Bruker balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 184.90M | 133.40M | 298.80M | 293.10M | 92.00M | 184.20M | 183.40M | 148.10M | 169.70M | 340.10M | 488.30M | 363.60M |
| Receivables | 545.90M | 542.70M | 544.90M | 550.90M | 522.60M | 537.80M | 565.50M | 538.40M | 507.20M | 475.40M | 492.00M | 485.40M |
| Inventory | 1.12B | 1.12B | 1.09B | 1.20B | 1.22B | 1.12B | 1.07B | 1.22B | 1.18B | 1.06B | 968.30M | 916.00M |
| Total Current Assets | 2.23B | 2.10B | 2.21B | 2.35B | 2.16B | 2.11B | 2.05B | 2.19B | 2.15B | 2.14B | 2.16B | 2.03B |
| Property, Plant & Equipment | 714.10M | 719.60M | 744.80M | 746.70M | 758.50M | 689.00M | 669.30M | 693.90M | 656.60M | 586.10M | 599.70M | 527.00M |
| Goodwill | 1.43B | 1.57B | 1.55B | 1.55B | 1.65B | 1.53B | 1.51B | 1.47B | 1.44B | 751.90M | 582.60M | 751.90M |
| Intangible Assets | 867.80M | 902.40M | 899.60M | 918.90M | 969.60M | 901.70M | 912.50M | 1.03B | 1.02B | 449.20M | 330.50M | 291.90M |
| Total Assets | 6.05B | 6.13B | 6.24B | 6.43B | 6.34B | 5.93B | 5.81B | 6.11B | 5.90B | 4.51B | 4.25B | 3.82B |
| Accounts Payable | 200.20M | 269.10M | 215.90M | 184.40M | 243.00M | 244.60M | 234.10M | 227.50M | 220.30M | 199.10M | 202.70M | 181.50M |
| Short-Term Debt | 10.10M | 8.40M | 16.60M | 24.30M | 55.70M | 37.70M | 32.50M | 32.80M | 26.40M | 21.20M | 121.20M | 121.00M |
| Total Current Liabilities | 1.20B | 1.36B | 1.28B | 1.27B | 1.35B | 1.34B | 1.28B | 1.32B | 1.30B | 1.18B | 1.20B | 1.07B |
| Long-Term Debt | 1.81B | 1.66B | 1.85B | 1.98B | 2.38B | 2.08B | 2.06B | 2.26B | 2.13B | 1.36B | 1.16B | 1.10B |
| Total Liabilities | 3.65B | 3.66B | 3.73B | 3.99B | 4.52B | 4.10B | 3.99B | 4.27B | 4.08B | 3.06B | 2.84B | 2.59B |
| Shareholders' Equity | 2.40B | 2.47B | 2.46B | 2.43B | 1.82B | 1.83B | 1.78B | 1.81B | 1.79B | 1.42B | 1.38B | 1.21B |
| Retained Earnings | — | — | 2.36B | 2.35B | — | — | 2.41B | 2.40B | 2.37B | 2.37B | 2.32B | — |
| Total Debt | 1.82B | 1.67B | 1.87B | 2.01B | 2.44B | 2.11B | 2.09B | 2.30B | 2.16B | 1.38B | 1.28B | 1.22B |
| Net Cash (Debt) | -1.64B | -1.54B | -1.57B | -1.72B | -2.34B | -1.93B | -1.91B | -2.15B | -1.99B | -1.04B | -793.20M | -856.00M |
| Shares Outstanding | 152.35M | 152.22M | 152.14M | 151.39M | 151.72M | 151.52M | 151.68M | 151.59M | 151.39M | 145.33M | 145.16M | 145.90M |
This table shows 12 quarterly periods of Bruker's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow BRKR's reporting calendar. What is a balance sheet?